Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | DSB2455 |
Synonyms | |
Therapy Description |
Limited information is currently available on DSB2455, a putative PARP1 inhibitor (Nov 2024). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
DSB2455 | DSB-2455|DSB 2455 | PARP-1 Inhibitor 10 | Limited information is currently available on DSB2455, a putative PARP1 inhibitor (Nov 2024). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06458712 | Phase I | DSB2455 | Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies | Recruiting | ESP | 0 |